3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
28
Neoplasm Metastasis
3
Carcinoma, Non-Small-Cell Lung
2
Urogenital Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumours
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Myelofibrosis
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Newly Diagnosed Oligometastatic Prostate Cancer
1
Neoplasms
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Multiple Myeloma
1
Metastatic Castration-resistant Prostate Cancer
1
Metastatic Castration-Resistant Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
Leukemia
1
Glioblastoma
1
Colorectal Neoplasms
1
Carcinoma, Small Cell
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
luprolide acetate gel depot
2
Leuprolide
2
Goserelin
2
radium Ra 223 dichloride
1
niraparib
1
apalutamide
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Watchful Waiting
1
Triptorelin Pamoate
1
Receptors, Bombesin
1
Radiotherapy
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Radiation
1
Observation
1
Neoadjuvant Therapy
1
Methods
1
Magnetic Resonance Spectroscopy
1
Gallium
1
Educational Status
1
Early Intervention, Educational
1
Counseling
1
Cholecalciferol
1
BAY 86-7548
1
Adjuvants, Pharmaceutic
1
68Ga-bombesin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Prostate Adenocarcinoma
×
abiraterone
×
Clear all
No trials found.